Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ – Get Free Report) shares rose 1.5% on Wednesday . The stock traded as high as $4.24 and last traded at $4.08. Approximately 250,715 shares changed hands during mid-day trading, an increase of 22% from the average daily volume of 205,918 shares. The stock had previously closed at $4.02.
Health Sciences Acquisitions Co. 2 Stock Performance
The company’s fifty day moving average is $4.38 and its 200-day moving average is $3.59.
Health Sciences Acquisitions Co. 2 Company Profile
Health Sciences Acquisitions Co 2 is a Delaware‐incorporated special purpose acquisition company (SPAC) established to pursue a business combination with a company in the health sciences sector. Listed on the Nasdaq under the ticker HSAQ, the firm completed an initial public offering in early 2021, raising capital through the sale of units comprised of common stock and warrants.
As a blank‐check vehicle, Health Sciences Acquisitions Co 2 does not engage in commercial operations; rather, it focuses exclusively on identifying and combining with a private company operating in biotechnology, pharmaceuticals, medical devices or related life sciences fields.
Featured Stories
- Five stocks we like better than Health Sciences Acquisitions Co. 2
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- When to buy gold (mathematically)
- NEW LAW: Congress Approves Setup For Digital Dollar?
- BREAKING: Elon Makes a Quiet Shift That Changes Everything
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Health Sciences Acquisitions Co. 2 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Sciences Acquisitions Co. 2 and related companies with MarketBeat.com's FREE daily email newsletter.
